Integra LifeSciences Holdings Corporation
IART · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,611 | $1,542 | $1,558 | $1,542 |
| % Growth | 4.5% | -1% | 1% | – |
| Cost of Goods Sold | $728 | $657 | $587 | $598 |
| Gross Profit | $882 | $885 | $970 | $945 |
| % Margin | 54.8% | 57.4% | 62.3% | 61.2% |
| R&D Expenses | $115 | $104 | $101 | $93 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $717 | $657 | $616 | $637 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $21 | $12 | $14 | $17 |
| Operating Expenses | $854 | $773 | $731 | $747 |
| Operating Income | $28 | $112 | $239 | $197 |
| % Margin | 1.8% | 7.2% | 15.3% | 12.8% |
| Other Income/Exp. Net | -$47 | -$30 | -$25 | $17 |
| Pre-Tax Income | -$18 | $81 | $214 | $215 |
| Tax Expense | -$11 | $13 | $33 | $46 |
| Net Income | -$7 | $68 | $181 | $169 |
| % Margin | -0.4% | 4.4% | 11.6% | 11% |
| EPS | -0.09 | 0.87 | 2.18 | 2 |
| % Growth | -110.4% | -60.1% | 9% | – |
| EPS Diluted | -0.09 | 0.84 | 2.16 | 1.98 |
| Weighted Avg Shares Out | 77 | 78 | 83 | 85 |
| Weighted Avg Shares Out Dil | 77 | 80 | 84 | 85 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $17 | $12 | $7 |
| Interest Expense | $71 | $51 | $50 | $50 |
| Depreciation & Amortization | $141 | $124 | $121 | $124 |
| EBITDA | $193 | $256 | $385 | $366 |
| % Margin | 12% | 16.6% | 24.7% | 23.7% |